Human Integrin alpha L/CD11a (Research Grade Efalizumab Biosimilar) Antibody, R&D Systems™

Integrin alpha L/CD11a

Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready

Monoclonal

Purified

RUO

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.

3683

IgG1

Protein A or G purified from cell culture supernatant

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.

Hu103-2

Flow Cytometry, CyTOF

Unconjugated

Human

Human

CD11 antigen-like family member A, CD11a, CD11a antigen, CD11Aantigen CD11A (p180), lymphocyte function-associated antigen 1, alphapolypeptide, integrin alpha-L, integrin gene promoter, integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen1; alpha polypeptide), ITGAL, Leukocyte adhesion glycoprotein LFA-1 alpha chain, Leukocyte function-associated molecule 1 alpha chain, LFA-1, LFA-1 alpha, LFA1A, LFA-1A, Ly-15, Ly-21, lymphocyte function-associated antigen 1

Human Integrin alpha L/CD11a

Primary

Reconstitute at 0.5 mg/mL in sterile PBS.